What is Within3?
Within3 operates at the intersection of healthcare technology and enterprise communication. By providing a purpose-built platform for life sciences organizations, the company facilitates complex, multi-stakeholder conversations that are critical to clinical development and commercialization. In an industry historically reliant on fragmented, manual outreach, Within3 offers a centralized, compliant, and scalable solution. This digital infrastructure enables companies to gather actionable insights, streamline advisory board interactions, and foster deeper engagement with the medical community, effectively modernizing the traditional pharmaceutical engagement model.
How much funding has Within3 raised?
Within3 has raised a total of $100M across 1 funding round:
Private Equity
$100M
Private Equity (2020): $100M with participation from Silversmith Capital Partners and Insight Partners
Key Investors in Within3
Silversmith Capital Partners
Silversmith Capital Partners is an investment firm that partners with entrepreneurs in the technology and healthcare sectors to build great companies.
Insight Partners
Insight Partners is a global venture capital and private equity firm investing in high-growth technology and software scale-ups.
What's next for Within3?
With this latest round of financing, Within3 is well-positioned to scale its operations and deepen its market penetration. The strategic focus will likely center on enhancing its proprietary software capabilities to meet the evolving regulatory and operational requirements of global life sciences firms. As the industry continues to prioritize digital-first strategies for clinical trial recruitment and medical affairs, Within3 is poised to leverage its capital to expand its footprint, potentially through product innovation or targeted market expansion. The backing from seasoned institutional investors provides the necessary runway to maintain its competitive edge in a rapidly digitizing healthcare landscape.
See full Within3 company page
